2003 IT Patients Provider 
Myriad Genetics
MAY 20, 2025
Whitnee Brown, a PMHNP and Doctor of Nursing Practice in Birmingham, Alabama, and her patient Lisa Roberts of Huntsville, shared their stories in support of the survey results, which can be viewed here. This spring’s survey focused on antidepressants and how Americans view them.
Georgetown Pediatrics & Family Medicine
JANUARY 24, 2022
The Joint National Committee 2003 defines hypertension as systolic of 140 mmHg and higher or diastolic 90 mmHg and higher. Many patients do not recognize elevated blood pressure as it can be subtle such as intermittent vision change or headaches. This reading may fluctuate throughout the day. What is my goal?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
SEPTEMBER 19, 2023
The FTC expressed concern that patent listings that do not meet the statutory criteria undermine the competitive process, may disincentivize investment in developing generic and follow-on products, and reduce patient access to more affordable drugs thereby increasing costs to the healthcare system. Koblitz & Kurt R.
Physician's Practice
JUNE 20, 2025
Reynolds Blog Article Innovative medical practices thrive by embracing change, prioritizing patient care and learning from setbacks to enhance success and satisfaction. Neil Baum, MD Successful practices do not follow others; rather, they make their own paths and follow their own pathways and agendas.
FDA Law Blog
MAY 25, 2022
The net effect will be that brand-name prices will remain higher for longer, and there will be fewer generic drugs available to patients. Section I provides data demonstrating the importance of the 180-day exclusivity incentive to generic competition. The new action-packed and data-driven report has three primary sections.
FDA Law Blog
FEBRUARY 27, 2024
For years after the enactment of the Hatch-Waxman Amendments the PTO interpreted the PTE statute to permit multiple PTEs, provided there are separate, but not necessarily different, regulatory review periods. 2003) , and Biogen lnt’l v. leave you scratching your head (we’ll call it “Who’s Buried in Grant’s Tomb?”). 351, 355-56 (1985).
GeriPal
MAY 18, 2023
And then there was a version in 2003 which Mark participated in and he since passed. We’ve invited two members who helped update the criteria including Todd Semla and Mike Steinman. Alex: We’re having Beers. laughter] Eric: Who do we have with us today? Alex: That’s what it was named after, right? We’ll learn about that.
Expert insights. Personalized for you.
52 
Let's personalize your content